Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in innovative cancer treatment through deep thermotherapy specifically targeting the head and neck region. As an Erasmus MC spinoff, the company focuses on developing novel hyperthermia techniques to enhance cancer care, providing a promising approach to improve treatment outcomes for patients suffering from tumors in these areas.
Developer of an automated disassembly and diagnostics solutions to maximize the value of every Li-ion battery. The company's proprietary computer vision models and robotic systems allow the autonomous handling of batteries of all variations, its disassembly process preserves material value and help companies to capture significant upcycling potential for cells and components, disassembly is entirely manual owing to wide variety in battery designs and changing conditions. enabling customers save significant cost, see positive carbon impacts vs recycling and find a solution to increasing labor shortage.
Beeodiversity is a company with a societal positif impact. Beeodiversity assists companies and local authorities to set up strategies and develop environmental projects generating added value for the environment, the partner and its stakeholders. It combines a scientific expertise, innovative tools based on nature and environmental coaching techniques.
Developer of autonomous greenhouse food production and indoor agriculture robots designed to automate tasks for food production in greenhouse horticulture sector industries. The company specializes in developing harvest and crop-handling robots and artificial intelligence-robotic harvester systems for indoor farming and eliminating factors like climate change and food security pressure, enabling farmers with a controlled climate and protection from the changes outside to get better yields with less land usage.
The Weed Whacker from Odd.Bot can be utilized via its Robot-as-a-Service offering and can be hired to clean any field of 10+ hectare. The intelligent robot -or robots- can detect both the weeds and crops already in an early stage and autonomously remove the weeds mechanically, specifically in the crop rows and in between the crops. Its biggest differentiators: sustainability: an alternative for (potential) harmful chemicals versatility: the spacing between the crops may vary resilience: it is highly adaptive and lightweight, which reduces soil compaction
Qu & Co is a developer of quantum-computational software focused on creating algorithms tailored for optimizing specialty chemicals, pharmaceuticals, and functional materials. The company's team of highly skilled quantum developers collaborates closely with clients and academic advisors to design innovative quantum algorithms and translate them into effective software solutions. Qu & Co's offerings enhance in-house discovery and optimization processes by advancing quantum-computational chemistry methods, seamlessly integrating with existing workflows in chemistry and material science. This enables clients in the pharmaceutical and other industries to conduct complex chemistry and multiphysics simulations on emerging quantum processors.
AMT Medical BV has developed a minimal invasive medical device for heart bypass surgery. The AMT Heart Bypass System is based on the ELANA bypass, technology invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team of the UMCU. The technique is designed to make the traditional heart bypass procedures faster, safer, easier and less invasive for the patient.The product has been fully developed, production process has been designed, all pre-clinical trials have finished, a clinical multi-center trial will commence late 2019, early 2020.
Resortecs – REcycling, SORting, TEChnologieS – is an award-winning start-up that develops Design for Disassembly solutions. We drive full circularity in the fashion industry with heat-dissolvable stitching threads and thermal disassembly systems that make industrial-scale textile recycling easy. Through targeted innovations in the way clothes are assembled and disassembled, our solutions empower fashion and workwear brands to rise to today’s environmental challenges at the pace and scale Earth needs. All without compromising the creativity, design, and quality of clothing. Resortecs' globally patented thermal disassembly solution is 5X faster than traditional disassembly methods and makes it possible to recycle up to 90% of the original fabric material: • Smart Stitich™, our heat-dissolvable stitching thread with different melting points (150 °C, 170 °C and 190 °C), enables brands to transform their products into recyclable, circular pieces from the manufacturing stage. • Smart Disassembly™, our thermal disassembly system, enables recyclers to unlock higher volumes of premium-quality material, processing up to 4M garments/year with low emissions and no material damage, so that fabrics can be used over and over again. Welcome to sustainability's next level: circularity.
Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).
Synergia Medical SA, founded in 2013 and based in Mont-Saint-Guibert, Belgium, specializes in the development of innovative neurostimulation medical devices. The company is focused on creating optoelectronic neurostimulators that utilize advanced materials, optical components, biosensors, and microelectronics. In particular, Synergia Medical aims to manufacture MRI-safe, implanted devices designed for treating drug-resistant epilepsy, with potential applications in other therapeutic areas. The company has achieved ISO13485 certification within a short period and has successfully developed and marketed an OEM external neurostimulator for motorized amputee prostheses. Supported by private investors and public research grants, Synergia Medical has rapidly expanded its team to include thirteen skilled professionals dedicated to advancing neurostimulation technology.
Quanturi Oy, founded in 2016 and based in Espoo, Finland, specializes in the development and provision of continuous monitoring solutions for fermentable products, catering to the agricultural, forestry, and waste sectors. The company offers a range of wireless monitoring systems, including those for compost temperature, grain management, and hay monitoring, ensuring the safety and quality of stored materials. Its platform provides real-time alerts for potential hazards, enhancing traceability and reducing handling costs. By enabling farmers and industry professionals to monitor their products effectively, Quanturi aims to prevent business disruptions and mitigate risks associated with spoilage or accidents. The company has expanded its presence across various countries, including France, Great Britain, the Netherlands, Switzerland, Italy, and Belgium, and sells its products online to reach a broader market.
ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of an anatomically shaped polymer-based meniscus implant known as the Trammpolin. This innovative implant is designed to restore the protective function of the meniscus by acting as a spacer in the joint. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise gained from a collaborative initiative that began in 2010, which included universities, private companies, and support from the Dutch government. The company combines clinical, biomechanical, and polymer knowledge to advance the Trammpolin design and its prototype development.
QuantWare engages in designing, developing, and fabricating hardware to enable quantum computing.
Hy2Care BV is a business start-up of the University of Twente, the Netherlands. It is Hy2Care’s ambition to introduce into the market the first cure for Osteoarthritis, the injectable hydrogel.
Osteoarthritis is the 4th leading cause of mobility associated disability and affects more than 100 million patients in the Western world, who are all in need for an effective treatment.
It is the aim of Hy2Care to change the future for patients suffering from osteoarthritis.
XenomatiX develops automotive Lidar solutions.
Xeltis AG is a clinical-stage medical device company based in Zurich, Switzerland, with additional research and development facilities in Eindhoven, the Netherlands. Founded in 2006, Xeltis focuses on developing bio-absorbable heart valves and blood vessels that facilitate the body's natural healing processes. Its innovative technology, known as RestoreX, employs a therapeutic approach called Endogenous Tissue Restoration (ETR), which allows patients' own bodies to generate new heart valves. Through ETR, the porous structure of Xeltis' heart valves, made from bioabsorbable polymers, enables tissue to integrate with the implant, gradually forming a fully functional valve while the device itself is absorbed by the body. This groundbreaking approach aims to transform the treatment of heart valve disease by restoring natural heart valve function.
Xeltis AG is a clinical-stage medical device company based in Zurich, Switzerland, with additional research and development facilities in Eindhoven, the Netherlands. Founded in 2006, Xeltis focuses on developing bio-absorbable heart valves and blood vessels that facilitate the body's natural healing processes. Its innovative technology, known as RestoreX, employs a therapeutic approach called Endogenous Tissue Restoration (ETR), which allows patients' own bodies to generate new heart valves. Through ETR, the porous structure of Xeltis' heart valves, made from bioabsorbable polymers, enables tissue to integrate with the implant, gradually forming a fully functional valve while the device itself is absorbed by the body. This groundbreaking approach aims to transform the treatment of heart valve disease by restoring natural heart valve function.
QphoX builds quantum modem device, connecting quantum computers across a quantum network.
VarmX B.V., a biotechnology company, develops therapies in the field of hemostasis and thrombosis. It develops PseudoXa, a therapeutic protein that is used to stop bleeding of patients who use blood thinners. The company was founded in 2016 and is based in Leiden, the Netherlands.
VarmX B.V., a biotechnology company, develops therapies in the field of hemostasis and thrombosis. It develops PseudoXa, a therapeutic protein that is used to stop bleeding of patients who use blood thinners. The company was founded in 2016 and is based in Leiden, the Netherlands.
Hardt Global Mobility, founded in 2016 and based in Delft, the Netherlands, specializes in the design and development of high-speed transportation systems. The company focuses on creating capsules that travel through vacuum tubes at speeds of up to 1,200 km/h. This innovative mode of transportation aims to enhance connectivity and accessibility, ultimately improving individual freedom and quality of life. By offering a fast and efficient means of travel, Hardt Global Mobility seeks to transform the way people move, connecting communities and making the world more accessible.
N2 Applied is a Norwegian technology company focused on innovative solutions for nitrogen fertilizer production directly on farms. Established in 2010 and headquartered in Oslo, the company has developed a method that allows livestock farmers to convert liquid organic substrates, such as manure and biogas digestate, into fertilizer by extracting nitrogen from the air. This process not only enhances the nitrogen content of the substrate but also mitigates ammonia loss and lowers greenhouse gas emissions. N2 Applied's technology promotes resource efficiency and cost savings for farmers by facilitating local fertilizer production, thus eliminating the need for long supply chains and reliance on fossil-based chemical fertilizers. The company's scalable system contributes to a circular farming model, offering additional benefits such as reductions in methane and ammonia emissions, as well as minimizing odors. N2 Applied operates a test center in Norway and has branches in the Netherlands and the UK, positioning itself within the realms of livestock farming, organic agriculture, and sustainable practices.
QphoX builds quantum modem device, connecting quantum computers across a quantum network.
iFLUX BVBA manufactures technology based iFLUX samplers to determine the speed and direction of groundwater flow and soil contamination. It offers flux measurement, which delivers information for groundwater. The company provides iFLUX technology, that measure the flow velocity of the groundwater and the spreading of the contamination. It also offers FLUXeye application. The company was founded in 2016 and is based in Niel, Belgium.
Sunrise aims to bring simple answers to millions of people suffering from sleep disorders. We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate as in-lab sleep studies, at a fraction of the cost. Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases. Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems.
Delmic B.V., based in Delft, the Netherlands, specializes in manufacturing correlative light and electron microscopy solutions aimed at advancing life and materials science research. The company’s primary products include SECOM, which integrates fluorescence and electron microscopy; SPARC, a high-performance cathodoluminescence detection system; and Delphi, a combined fluorescence and scanning electron microscope. Delmic also develops software designed to facilitate navigation within its integrated microscopy systems. Founded in 2010, the company is committed to providing effective and user-friendly tools that enhance research capabilities, enabling researchers and organizations to gain insights more efficiently.
Microsure B.V., founded in 2016 and based in Son, Netherlands, specializes in the development of advanced robotic systems for microsurgery. The company's flagship product, MUSA, is designed to assist surgeons in performing intricate procedures, including lymphatic surgery, free flap surgery, and hand surgery. The Microsure motion stabilizer system enhances surgical precision and control, addressing the physical limitations faced by microsurgeons. This technology aims to improve the quality of microsurgical procedures, thus expanding treatment options for patients. The system has demonstrated its efficacy in clinical trials, successfully facilitating microsurgical operations for lymphedema at Maastricht UMC+. Microsure is focused on accelerating the market introduction and sales of its innovative surgical systems.
Plant-e is a pioneering company that specializes in harnessing the power of living plants to generate electricity. Founded in 2009 as a spin-off from Wageningen University, the company focuses on developing technology that enables power generation without harming the plants. Utilizing plant-microbial fuel cells, Plant-e captures electrons from the soil and converts them into electrical energy. This innovative approach allows for the creation of power sources from green roofs, wetlands, and rice paddies, effectively transforming them into sustainable energy providers. Marjolein Helder, who has been the CEO since her PhD graduation in 2012, leads the company, while David Strik continues to bridge the gap between scientific research and product development.
Sensius B.V., founded in 2015 and based in Rotterdam, Netherlands, specializes in innovative cancer treatment through deep thermotherapy specifically targeting the head and neck region. As an Erasmus MC spinoff, the company focuses on developing novel hyperthermia techniques to enhance cancer care, providing a promising approach to improve treatment outcomes for patients suffering from tumors in these areas.
Developer of microbiome analysis technology designed to monitor the microbiome status and function and quantify its impact on all aspects of human life. The company's technology simplifies, accelerates, and democratizes microbiome analysis to precisely measure the composition and dynamics of the microbiome by uncovering its role in human health and the environment, enabling researchers to access genetic analysis devices to analyze the full genetic makeup of microbiomes.
Developer of microbiome analysis technology designed to monitor the microbiome status and function and quantify its impact on all aspects of human life. The company's technology simplifies, accelerates, and democratizes microbiome analysis to precisely measure the composition and dynamics of the microbiome by uncovering its role in human health and the environment, enabling researchers to access genetic analysis devices to analyze the full genetic makeup of microbiomes.
QphoX builds quantum modem device, connecting quantum computers across a quantum network.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
We build control hardware for quantum computers. Quantum computers will revolutionize the way we compute by embedding the laws of quantum mechanics in their fundamental building blocks (qubits). To get from the current proof-of-principle prototype quantum computers to earth-shattering computation power, many scientific and engineering challenges have to be solved. Our company has the mission to build the control hardware stacks that can manage the upcoming generations of quantum processors.
e-peas SA specializes in the design and manufacture of energy autonomous systems for Internet of Things (IoT) applications. Founded in 2014 and based in Mont-Saint-Guibert, Belgium, the company focuses on creating solutions that enable IoT nodes to harness energy from their environment, including sources such as solar, thermal, vibration, and radiofrequency. e-peas develops energy harvesting power management integrated circuits (PMICs) and microcontrollers that enhance the performance and efficiency of IoT devices by extending battery life or eliminating the need for battery replacements altogether. Their products serve various sectors, including home automation, industry, retail, smart metering, healthcare, mobility, security, and agriculture, contributing to smarter, more sustainable technology solutions.
At Quantib we come to work every day to help physicians solve the hardest challenges they face when diagnosing patients. Our smart software analyzes medical images to unravel secrets hidden to the naked eye. Are you excited to learn more about how artificial intelligence techniques can move healthcare forward and help our marketing department tell this story to the world? We’d love for you to join our tight team of 22 conquering the medical world with deep learning software.
Onera B.V. specializes in providing sleep diagnostic solutions aimed at diagnosing sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and based in Eindhoven, the Netherlands, the company employs innovative sleep diagnostic patch systems that collect and analyze sleep data to facilitate accurate diagnoses. These systems are designed to be comfortable and user-friendly, akin to wearing a band-aid, making them accessible for patients. Onera B.V. is a spin-off of imec, a leading research center in nanoelectronics and digital technology, and focuses on advancing sleep medicine through its breakthrough solutions. With a mission to improve the health and quality of life for individuals suffering from sleep-related ailments, Onera aims to provide essential diagnostic services that address the needs of millions worldwide.
Ventinova Medical, founded in 2013, focuses on the development and marketing of innovative medical devices for airway management and patient ventilation. The company specializes in creating single-use ventilation devices designed to control both inspiration and expiration during artificial airflow, actively assisting in the removal of gases from the lungs. This unique approach enhances patient recovery, particularly in critical situations where blood flow and oxygen saturation are compromised. Ventinova aims to revolutionize traditional ventilation practices by leveraging advanced technology and extensive medical expertise to deliver solutions that exceed current standards in the medical field.
Ventinova Medical, founded in 2013, focuses on the development and marketing of innovative medical devices for airway management and patient ventilation. The company specializes in creating single-use ventilation devices designed to control both inspiration and expiration during artificial airflow, actively assisting in the removal of gases from the lungs. This unique approach enhances patient recovery, particularly in critical situations where blood flow and oxygen saturation are compromised. Ventinova aims to revolutionize traditional ventilation practices by leveraging advanced technology and extensive medical expertise to deliver solutions that exceed current standards in the medical field.
Hiber is a company based in Amsterdam, founded in 2016, that specializes in satellite broadband services. The company offers a nano-satellite platform, known as Hiberband®, which is designed to provide low-cost Internet of Things (IoT) data connectivity for sensors across remote locations globally. Hiber's technology facilitates easy, low-power network access, allowing users to monitor and gather data from various environments, including water wells, agricultural fields, and transportation systems. The platform enables the transmission of small data packages, delivering actionable insights from anywhere in the world, thus transforming how connectivity and monitoring are approached in diverse sectors.
Plasmacure, located in Eindhoven, the Netherlands, focuses on developing cold plasma technology aimed at treating chronic wounds, particularly diabetic foot wounds. This innovative approach not only targets and eliminates bacteria but also promotes cell proliferation and enhances microcirculation. By addressing these critical factors, Plasmacure's technology helps healthcare professionals reduce the risk of amputation and improve the overall quality of life for patients suffering from chronic wounds.
FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians.
Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.
FEops is a recognized pioneer in the field of physics-based simulations for minimally invasive cardiovascular devices and procedures. They apply this technology from bench to bed, by offering advice to medical device companies as well as to medical specialists and physicians.
Their computer simulations have proven to provide medical device developers and manufacturers with unique insights, thereby speeding up R&D processes and supporting device safety. Physicians, for their part, benefit from new patient-specific insights that help them work more efficiently while, most importantly, improving patient safety.
S-Biomedic is a Belgian biotech company specializing in live probiotic cosmetics designed to improve skin health. The company focuses on the skin microbiome, a complex ecosystem of beneficial and harmful bacteria that plays a crucial role in skin conditions such as acne, eczema, rosacea, and aging. S-Biomedic employs advanced modulation-based technology to selectively harness beneficial bacteria, creating products that promote the rebalancing of the skin microbiome. By utilizing the latest advancements in microbiology and dermatology, their offerings aim to restore healthy skin and address various dermatological concerns. Through this innovative approach, S-Biomedic provides therapeutic solutions in both the dermatology and cosmetic sectors, enhancing the overall health and beauty of the skin.
Tessares is a Belgian company founded in 2015, specializing in software solutions aimed at enhancing the performance and quality of internet access. It focuses on developing and deploying Multipath TCP (MPTCP) technology, which allows network operators to combine various access technologies to improve internet speed for their customers. The company's flagship product, the Hybrid Access Solution, enables the efficient bonding of different network connections without the need for extensive infrastructure investments. Founded by key developers of the MPTCP protocol, Tessares aims to optimize internet delivery across wide geographic areas, ensuring a better overall experience for users. The company is privately owned and has secured initial funding from notable investors, including Proximus and VIVES.